AUSTIN, Texas–(BUSINESS WIRE)–Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in
less invasive medical devices for gastrointestinal and bariatric
procedures, announced today that company management is scheduled to
present at the JMP Securities 2019 Life Sciences Conference being held
June 19-20, 2019 at the St. Regis New York. The presentation is
scheduled for Wednesday, June 19, 2019 at 11:30 am ET.
An audio replay of the presentation will be available for 90 days
following the presentation on Apollo’s website, www.apolloendo.com.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less
invasive therapies to treat various gastrointestinal conditions, ranging
from gastrointestinal defect repairs to the interventional treatment of
obesity. Apollo’s device-based therapies are an alternative to invasive
surgical procedures, thus lowering complication rates and reducing total
healthcare costs. Apollo’s products are offered in over 70 countries
today and include the OverStitch™ Endoscopic Suturing System, the
OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric
Apollo’s common stock is traded on Nasdaq Global Market under the symbol
“APEN”. For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
Apollo Endosurgery, Inc.
John Gillings, 512-279-5100